Recent studies suggest, PRDX1 reduces the production of pro-inflammatory cytokines IL-8 and CXCL1 [106], or interacts with poly(ADP-ribose) polymerase (PARP) tankyrase to promote tumor development via the adenomatous polyposis coli (APC) gene [107]. Here, APC is linked to neoplasm.